Article Versions Notes

Suñer C, Escrig-Sarreta R, Galván-Casas C, Matos E, Gabster A, Wolff M, Ouchi D, Alemany A, Sánchez H, Huaman S, et al. Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations. Vaccines. 2025; 13(6):594. https://doi.org/10.3390/vaccines13060594

Suñer, Clara, Roser Escrig-Sarreta, Cristina Galván-Casas, Eduardo Matos, Amanda Gabster, Marcelo Wolff, Dan Ouchi, Andrea Alemany, Hugo Sánchez, Sandra Huaman, and et al. 2025. "Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations" Vaccines 13, no. 6: 594. https://doi.org/10.3390/vaccines13060594

Suñer, C., Escrig-Sarreta, R., Galván-Casas, C., Matos, E., Gabster, A., Wolff, M., Ouchi, D., Alemany, A., Sánchez, H., Huaman, S., Bejarano, D., Carrés-Esteve, L., Santiago-Fernández, C., Corral-Rubio, J., Mendoza, A., Rivero, À., Descalzo, V., Orviz, E., Martínez-Riveros, H., ... REMAIN Study Group. (2025). Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations. Vaccines, 13(6), 594. https://doi.org/10.3390/vaccines13060594